Algert Coldiron Investors »

Rapport Therapeutics shares owned by Algert Coldiron Investors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Algert Coldiron Investors from 13F filings

Historical chart of Algert Coldiron Investors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Algert Coldiron Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Algert Coldiron Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.3M 224k 41.67